AMOXICILLIN/CLAVULANATE IN THE TREATMENT OF INFECTIONS OF RESPIRATORY SYSTEM AND ENT-ORGANS IN CHILDREN: WHAT DOSE TO CHOOSE?


如何引用文章

全文:

详细

Amoxicillin/clavulanate is widely used in clinical practice for 30 years. This drug has highly stable activity against the major bacterial pathogens of the respiratory system and ENT-organs in children: Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Due to the high level of resistance of pneumococcus to penicillin, the use of high-dose amoxicillin (80-90 mg/kg/day) is recommended in a number of countries. Currently, amoxicillin/clavulanate at a dose of 40-45 mg/kg/day (per amoxicillin) is possible to use in Russia. Administration of amoxicillin/clavulanate with a high content of amoxicillin is reasonable only in patients with risk of infection by penicillin-resistant pneumococcus.

参考

  1. Справочник по антимикробной терапии. Смоленск, 2006. 384 с.
  2. Козлов С.Н., Страчунский Л.С. Пенициллины. Часть I. Природные и полусинтетические пенициллины // Клиническая антимикробная химиотерапия. 2000. Т. 2. № 1. С. 32-8.
  3. Williams JD. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin Infect Dis 1997;24(3):494-97.
  4. Практическое руководство по антиинфекционной химиотерапии / Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Смоленск, 2007. 464 с.
  5. Козлов С.Н., Страчунский Л.С. Пенициллины. Часть II. Ингибиторозащищенные и комбинированные пенициллины // Клиническая антимикробная химиотерапия. 2000. Т. 2. № 2. С. 67-70.
  6. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 2010;23(1):160-201.
  7. Smith GM, Slocombe B, Abbott KH, et al. Activity of amoxicillin-clavulanate against penicillin-resistant Streptococcus pneumoniae in an experimental respiratory infection model in rats. Antimicrob Agents Chemother 1998;42(4):813-17.
  8. White AR, Kaye C, Poupard J, et al. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 2004;53(Suppl. 1):3-20.
  9. Проект ЭРА (экспертные рекомендации по антибиотикотерапии). Современные режимы дозирования пероральных аминопенициллинов // Клиническая микробиология и антимикробная химиотерапия. 2004. Т. 6. C. 224-31.
  10. Jacobs MR, Felmingham D, Appelbaum PC, et al. Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52(2):229-46.
  11. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113(5):1451-65.
  12. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001;20(9):829-37.
  13. Hoberman A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J 2005;24(6):525-32.
  14. American Academy of Pediatrics. Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics 2001;108(3):798-808.
  15. Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009;124(1):9-15.
  16. Grant GB, Campbell H, Dowell SF, et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9(3):185-96.
  17. Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. М., 2010. 106 с.
  18. Козлов Р.С. Пути оптимизации мониторинга, профилактики и фармакотерапии пневмококковых инфекций. Автореф. дис. докт. мед. наук. Смоленск, 2004. 46 с.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##